Perclose ProGlide Suture-Mediated Closure System and Perclose ProStyle Suture-Mediated Closure and Repair System
Abbott Vascular, Inc. · Decision date Aug 27, 2026
What did the FDA approve?
FDA records P960043/S128 as a supplement to PMA P960043, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Aug 27, 2026.
FDA approval order statement
approval for a change to the final packaging for the Perclose ProGlide Suture-Mediated Closure System and PerClose ProStyle Suture Mediated Closure and repair system
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 27, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P960043/S128
- Regulatory pathway
- PMA supplement
- Applicant
- Abbott Vascular, Inc.
- Product code
- MGB
- Decision code
- APPR
- Decision date
- Aug 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Device, hemostasis, vascular.
- Applicant
- Abbott Vascular, Inc.
- Product code
- MGB
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P960043. Subsequent supplements may change the device or its indications.
FDA decision timeline
P960043 · Original PMA
PROSTAR 9 FR. PERCUTANEOUS VASCULAR SURGICAL (PVS) SYSTEM
P960043/S128 received
Application receipt date recorded by FDA.
P960043/S127 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Prostar XL Percutaneous Vascular Surgical System
P960043/S129 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S130 · Related supplement
Perclose ProGuide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S131 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S132 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S133 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S134 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S136 · Related supplement
Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S128 · FDA decision
Real-Time Process
P960043/S137 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S138 · Related supplement
Perclose ProStyle Suture-Mediated Closure and Repair System
P960043/S139 · Related supplement
Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System
Timeline entries are records held by MedtechLedger for P960043. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960043
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott Vascular, Inc. | PMA approval | Apr 30, 1997 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Dec 9, 2025 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Feb 10, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Feb 11, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Mar 2, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Apr 1, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Apr 17, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | May 22, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Jul 14, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Oct 26, 2026 | FDA | |
| Abbott Vascular, Inc. | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code MGB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CELT ACD VASCULAR CLOSURE DEVICEP150006/S009 | Vasorum, Ltd. | PMA supplement | Oct 30, 2026 | FDA |
| Vivasure Medical , Ltd. | PMA approval | Oct 16, 2026 | FDA | |
VASCADE 5F Vascular Closure SystemP120016/S043 | Cardiva Medical, Inc. | PMA supplement | Sep 10, 2026 | FDA |
Angio Seal VIP Vascular Closure DeviceP930038/S107 | Terumo Medical Corporation | PMA supplement | Aug 4, 2026 | FDA |
Exoseal Vascular Closure DeviceP100013/S034 | Cordis US Corporation | PMA supplement | Jun 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 400 Saginaw Dr., Redwood, CA, 94063
Sources and methodology
- Original FDA record: P960043/S128
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






